<DOC>
	<DOCNO>NCT00313131</DOCNO>
	<brief_summary>This randomise controlled trial aim verify whether directly observe single dose treatment ( tinidazole+fluconazole ) would effective long standard treatment ( metronidazole 7 day , plus vaginal clotrimazole 3 day ) syndromic management woman present vaginal discharge primary health care center Ghana , Togo , Guinea Mali . It design effectiveness trial , i.e . do condition typical routine work health center</brief_summary>
	<brief_title>Study Management Vaginal Discharge West African Using Single Dose Treatments</brief_title>
	<detailed_description>Abstract Objective : Evaluate whether single-dose treatment effective standard therapy syndromic management vaginal discharge . Methods : A randomize controlled effectiveness trial compare single-dose tinidazole plus fluconazole ( TF ) seven day metronidazole plus three day vaginal clotrimazole ( MC ) among 1570 woman present vaginal discharge primary health care institution Ghana , Togo , Guinea Mali . Participants randomly allocate one two treatment research nurse physicians use pre-coded envelope . Effectiveness assess symptomatic response day 14 . Findings : The two treatment regimen similar effectiveness : complete resolution see 66 % ( TF ) 64 % ( MC ) partial resolution 33 % ( TF ) 34 % ( MC ) participant ( p=0.26 ) . Effectiveness similar among subgroups vulvovaginal candidiasis , T. vaginalis vaginitis bacterial vaginosis . The two treatment regimen similar effectiveness among HIV-infected ( TF : n=76 , 71 % complete resolution , 28 % partial ; MC : n=83 , 72 % complete , 25 % partial , p=0.76 ) HIV-uninfected woman ( TF : n=517 , 68 % complete , 32 % partial ; MC : n=466 , 65 % complete , 33 % partial , p=0.20 ) . Cervical infection N. gonorrhoeae , C. trachomatis M. genitalium uncommon among woman involve sex work , associate bacterial vaginosis T. vaginalis vaginitis , alter response treatment agent active vaginal infection . Four fifths woman relieve single-dose TF favourable response MC administer second-line treatment . Conclusion : Single-dose TF effective multiple-dose MC syndromic management vaginal discharge , even among HIV-infected . Given low price easy compliance , tinidazole/fluconazole consider first-line treatment vaginal discharge syndrome .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Vaginal Discharge</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Tinidazole</mesh_term>
	<criteria>woman consult vaginal discharge local resident willingness ability consent sex worker consult active screening main complaint lower abdominal pain allergy one study drug</criteria>
	<gender>Female</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>bacterial vaginosis</keyword>
	<keyword>vaginal candidiasis</keyword>
	<keyword>trichomoniasis</keyword>
	<keyword>vaginitis</keyword>
	<keyword>Ghana</keyword>
	<keyword>Togo</keyword>
	<keyword>Mali</keyword>
	<keyword>Guinea</keyword>
</DOC>